{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:26:38Z","timestamp":1790799998971,"version":"4.1.0"},"reference-count":16,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,3,1]]},"DOI":"10.1093\/europace\/euw416","type":"journal-article","created":{"date-parts":[[2017,2,8]],"date-time":"2017-02-08T14:31:44Z","timestamp":1486564304000},"page":"420-428","source":"Crossref","is-referenced-by-count":47,"title":["Stroke and bleeding with non-vitamin K antagonist oral anticoagulant or warfarin treatment in patients with non-valvular atrial fibrillation: a population-based cohort study"],"prefix":"10.1093","volume":"20","author":[{"given":"Tomas","family":"Forslund","sequence":"first","affiliation":[{"name":"Clinical Epidemiology\/Clinical Pharmacology, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital Solna, SE-171 76 Stockholm, Sweden"},{"name":"Department of Healthcare Development, Stockholm County Council, Public Healthcare Services Committee, Karolinska University Hospital Solna, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Wettermark","sequence":"additional","affiliation":[{"name":"Department of Healthcare Development, Stockholm County Council, Public Healthcare Services Committee, Karolinska University Hospital Solna, Stockholm, Sweden"},{"name":"Department of Medicine Solna, Centre for Pharmacoepidemiology, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Andersen","sequence":"additional","affiliation":[{"name":"Department of Medicine Solna, Centre for Pharmacoepidemiology, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Hjemdahl","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology\/Clinical Pharmacology, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital Solna, SE-171 76 Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,2,10]]},"reference":[{"key":"key\n\t\t\t\t20180227065248_euw416-B1"},{"key":"key\n\t\t\t\t20180227065248_euw416-B2"},{"key":"key\n\t\t\t\t20180227065248_euw416-B3","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s00228-014-1739-1","article-title":"Risks for stroke and bleeding with warfarin or aspirin treatment in patients with atrial fibrillation at different CHA(2)DS(2)VASc scores: experience from the Stockholm region","volume":"70","author":"Forslund","year":"2014","journal-title":"Eur J Clin Pharmacol"},{"key":"key\n\t\t\t\t20180227065248_euw416-B4","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ijcard.2013.10.063","article-title":"Risk scoring and thromboprophylactic treatment of patients with atrial fibrillation with and without access to primary healthcare data: experience from the Stockholm health care system","volume":"170","author":"Forslund","year":"2013","journal-title":"lnt J Cardiol"},{"key":"key\n\t\t\t\t20180227065248_euw416-B5","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180227065248_euw416-B6","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180227065248_euw416-B7","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180227065248_euw416-B8","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0140-6736(10)61194-4","article-title":"Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial","volume":"376","author":"Wallentin","year":"2010","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180227065248_euw416-B9","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1161\/CIRCULATIONAHA.112.142158","article-title":"Efficacy and safety of apixaban compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation","volume":"127","author":"Wallentin","year":"2013","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180227065248_euw416-B10","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.112.000067","article-title":"Impact of global geographic region on time in therapeutic range on warfarin anticoagulant therapy: data from the ROCKET AF clinical trial","volume":"2","author":"Singer","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"key\n\t\t\t\t20180227065248_euw416-B11","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1001\/jamacardio.2016.0199","article-title":"Outcomes in a warfarin-treated population with atrial fibrillation","volume":"1","author":"Bj\u00f6rck","year":"2016","journal-title":"JAMA Cardiol"},{"key":"key\n\t\t\t\t20180227065248_euw416-B12","doi-asserted-by":"crossref","first-page":"i3189","DOI":"10.1136\/bmj.i3189","article-title":"Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study","volume":"353","author":"Larsen","year":"2016","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20180227065248_euw416-B13","doi-asserted-by":"crossref","first-page":"e003725","DOI":"10.1161\/JAHA.116.003725","article-title":"Effectiveness and safety of dabigatran, rivaroxaban, and apixaban versus warfarin in nonvalvular atrial fibrillation","volume":"5","author":"Yao","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"key\n\t\t\t\t20180227065248_euw416-B14","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jacc.2014.10.052","article-title":"Benefit of anticoagulation unlikely in patients with atrial fibrillation and a CHA2DS2-VASc score of 1","volume":"65","author":"Friberg","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180227065248_euw416-B15","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1160\/TH16-05-0400","article-title":"Usefulness of health registers for detection of bleeding events in outcome studies","volume":"116","author":"Friberg","year":"2016","journal-title":"Thromb Haemost"},{"key":"key\n\t\t\t\t20180227065248_euw416-B16","doi-asserted-by":"crossref","DOI":"10.1002\/9780470258019","volume-title":"Applied Survival Analysis: Regression Modeling of Time-To-Event Data","author":"Hosmer","year":"2008","edition":"2nd ed"}],"container-title":["EP Europace"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/europace\/article-pdf\/20\/3\/420\/24186229\/euw416.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T04:26:40Z","timestamp":1692678400000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/20\/3\/420\/2978055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,10]]},"references-count":16,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,2,10]]},"published-print":{"date-parts":[[2018,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euw416","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,3]]},"published":{"date-parts":[[2017,2,10]]}}}